Shenzhen Guandebao Information Technology Co., Ltd – Trademark Portfolio
Entity Type: 16
Shenzhen Guandebao Information Technology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include CIYOSMIL and LHIBYOLO. The owner is based in Shenzhen City.
No. 322, Dongfang Village, Songgang St
Shenzhen City 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Guandebao Information Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Guandebao Information Technology Co., Ltd have?
Shenzhen Guandebao Information Technology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shenzhen Guandebao Information Technology Co., Ltd file in?
Shenzhen Guandebao Information Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Guandebao Information Technology Co., Ltd's most well-known trademarks?
Shenzhen Guandebao Information Technology Co., Ltd's registered trademark portfolio includes well-known marks such as CIYOSMIL and LHIBYOLO. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen Guandebao Information Technology Co., Ltd's trademark registration success rate?
Shenzhen Guandebao Information Technology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.